Gene therapy could treat inherited blindness

Article

DNA elements have been identified that control when and where genes linked to blindness are "switched on".

DNA elements have been identified that control when and where genes linked to blindness are "switched on", according to researchers at Washington University School of Medicine, St Louis, USA.

Using a computational analysis of DNA to search for elements that can turn on genes in the photoreceptor cells of the eye, the investigators have identified hundreds of potential cis-regulatory elements (DNA segments involved in activating and deactiviating genes). Nineteen of these elements have now been confirmed, more than doubling the number previously identified.

The results of this study will be used to design gene therapy vectors for a form of Leber's congenital amaurosis, an inherited disorder that leaves patients blind from birth.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.